Kal Dorji is an accomplished professional in the pharmaceutical and regulatory consulting fields, currently serving as the Owner and CEO of Elixa Health Associates, a leading regulatory consulting firm for the US e-vapor industry since October 2014. Dorji provides expertise in FDA regulatory compliance submissions, quality management systems, and analytical testing for liquid and aerosol emissions. Additionally, Kal Dorji is a member of the Board of Directors for the Academy of Compounding Pharmacists under the California Pharmacists Association and previously held roles as a Consulting/Prior Authorization Pharmacist at Optum and as a Compounding Pharmacist at California Pharmacy & Compounding Center. Dorji's career also includes leadership as Local Association President for the California Pharmacists Association and experience as a Pharmacy Intern and Pharmacist at Rite Aid Pharmacy. Education credentials include a Pharm D. from the University of Southern California, obtained from 2003 to 2010.